The ability to adjust the therapeutic regimen (insulin administration and timing, type and quantity of food ingestion before and after physical exercise) that allows safe participation and high performance has recently been recognized as an important management strategy in individuals with T1DM. This evidence concerns the gene INS and type 1 diabetes mellitus.